|
Volumn 245, Issue 3, 1998, Pages
|
Medical treatment of Parkinson's disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPRAZOLAM;
AMANTADINE;
ANTIHISTAMINIC AGENT;
ANTIOXIDANT;
APOMORPHINE;
BENSERAZIDE PLUS LEVODOPA;
BROMOCRIPTINE;
CABERGOLINE;
CARBIDOPA PLUS LEVODOPA;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CISAPRIDE;
CLOZAPINE;
DECARBOXYLASE INHIBITOR;
DIAZEPAM;
DOMPERIDONE;
DOPAMINE RECEPTOR STIMULATING AGENT;
LEVODOPA;
LISURIDE;
LORAZEPAM;
MONOAMINE OXIDASE INHIBITOR;
MUSCARINIC RECEPTOR BLOCKING AGENT;
PERGOLIDE;
PETHIDINE;
PIRIBEDIL;
PRAMIPEXOLE;
QUETIAPINE;
ROPINIROLE;
SELEGILINE;
SEROTONIN UPTAKE INHIBITOR;
TRANYLCYPROMINE;
CHEMOPROPHYLAXIS;
CONFERENCE PAPER;
DEPRESSION;
DYSKINESIA;
ELECTROCONVULSIVE THERAPY;
HUMAN;
ORAL DRUG ADMINISTRATION;
PARKINSON DISEASE;
PHYSIOTHERAPY;
PRIORITY JOURNAL;
PSYCHOSIS;
SIDE EFFECT;
|
EID: 0031658947
PISSN: 09391517
EISSN: None
Source Type: Journal
DOI: 10.1007/pl00007742 Document Type: Conference Paper |
Times cited : (26)
|
References (2)
|